Akti-1/2 Blocks LPA-Mediated COX-2 Expression

Medical University of Graz
Division of Cardiology
Lab Technician

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

Tocris Bioscience

Product Name:

Akti-1 / 2

Catalog Number:

5773/10

LPA treatment induced Akt phosphorylation in osteosarcoma cells. Therefore, we used Akt-1/2 to investigate role of Akt in COX-2 activation.

Experimental Design and Results Summary

Application

Cell culture

Starting Material

Human osteosarcoma cells

Protocol Overview

Human osteosarcoma cells were incubated with 10 μM Akti-1/2 for 30 min prior to treatment with 10 μM LPA to estimate COX-2 expression using Western blot analysis.

Tips

N/A

Results Summary

Akti-1/2 abolished LPA-induced COX-2 expression.

DOI or PMID #

N/A

Additional Notes

N/A

Image Gallery

Summary

The Good

Worked as expected

The Bad

N/A

The Bottom Line

Akt-1/2 is a selective and effective Akt inhibitor.

Join the discussion